Overall rank by patents
#3,590
Across all tracked assignees
USPTO PatentsView assignee record - 102 granted patents across 110 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C22C (ALLOYS).
The verdict
Central holds 102 US patents across 110 technology areas, rank #3,590 of 50,000 tracked assignees.
Central South University has been granted 102 US utility patents between 2015 and 2025, placing Central South University at rank #3,590 across all assignees tracked by PlainPatent. This portfolio spans 110 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.0 claims per patent with primary concentration in C22C (ALLOYS). As a Foreign Government, Central South University is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Central sits between Amarin Pharmaceuticals Ireland Limited (102 patents, rank #3,586) and G.d Societa' PER Azioni (102 patents, rank #3,594) - the closest US assignees by grant volume. The composite Innovation Score of 67.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 93 grants, compared with 9 in the 2015–2019 window, a +933% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Government classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Central South University's 11.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Central South University against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AMARIN PHARMACEUTICALS IRELAND LIMITED
102 patents
Afero, Inc.
102 patents
Aveva Software, LLC
102 patents
BOSTIK SA
102 patents
Colder Products Company
102 patents
Corcept Therapeutics Incorporated
102 patents
DUPONT NUTRITION BIOSCIENCES APS
102 patents
G.D SOCIETA' PER AZIONI
102 patents
CENTRAL SOUTH UNIVERSITY
102 patents
What this shows Central holds 102 patents at rank #3,590, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,590 in granted patent volume.
Other assignees with the most granted patents in Central's primary technology class.
Central's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
68 Top 1% higher than 99% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 1.0% |
| 2018 | 1 | 1.0% |
| 2019 | 7 | 6.9% |
| 2020 | 6 | 5.9% |
| 2021 | 7 | 6.9% |
| 2022 | 11 | 10.8% |
| 2023 | 18 | 17.6% |
| 2024 | 32 | 31.4% |
| 2025 | 19 | 18.6% |
Top 15 of 110 technology areas
Overall rank by patents
#3,590
Across all tracked assignees
67.6 out of 100
How to use this portfolio
Central's 102 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.